72.51
price down icon0.33%   -0.24
pre-market  시장 영업 전:  72.60   0.09   +0.12%
loading
전일 마감가:
$72.75
열려 있는:
$73.5
하루 거래량:
1.66M
Relative Volume:
1.05
시가총액:
$12.97B
수익:
$342.96M
순이익/손실:
$-864.29M
주가수익비율:
-13.06
EPS:
-5.55
순현금흐름:
$-636.03M
1주 성능:
+11.13%
1개월 성능:
-1.81%
6개월 성능:
-4.01%
1년 성능:
+151.68%
1일 변동 폭
Value
$71.50
$73.62
1주일 범위
Value
$63.73
$73.62
52주 변동 폭
Value
$21.92
$80.53

Insmed Inc Stock (INSM) Company Profile

Name
명칭
Insmed Inc
Name
전화
908-977-9900
Name
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
직원
912
Name
트위터
@insmed
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
INSM's Discussions on Twitter

INSM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
INSM
Insmed Inc
72.51 12.97B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Insmed Inc Stock (INSM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-23 개시 Truist Buy
2024-02-15 개시 Wolfe Research Outperform
2023-12-08 개시 Wells Fargo Overweight
2023-11-20 재개 JP Morgan Overweight
2023-07-26 개시 Guggenheim Buy
2022-12-09 개시 Mizuho Buy
2022-12-07 개시 Barclays Overweight
2022-11-18 개시 BofA Securities Buy
2022-04-27 개시 Goldman Buy
2021-12-06 개시 JP Morgan Overweight
2021-10-19 재개 Monness Crespi & Hardt Buy
2021-10-19 재개 Morgan Stanley Overweight
2021-10-08 개시 Cantor Fitzgerald Overweight
2021-04-26 재개 Credit Suisse Outperform
2020-12-17 개시 Berenberg Buy
2020-10-12 재개 Stifel Buy
2019-09-03 개시 Goldman Buy
2019-04-09 재확인 H.C. Wainwright Buy
2019-02-15 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 업그레이드 Goldman Neutral → Buy
2019-01-02 개시 Canaccord Genuity Buy
2018-08-06 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 개시 Goldman Neutral
2018-04-23 업그레이드 Credit Suisse Neutral → Outperform
2018-03-21 개시 Morgan Stanley Overweight
2018-01-18 개시 Credit Suisse Neutral
2017-09-05 재확인 Evercore ISI Outperform
2017-08-17 개시 Evercore ISI Outperform
2017-07-11 개시 Robert W. Baird Outperform
2016-03-15 개시 Stifel Buy
2015-11-09 다운그레이드 UBS Buy → Neutral
2015-10-06 재확인 H.C. Wainwright Buy
2015-06-09 개시 Citigroup Neutral
2014-03-26 재확인 HC Wainwright Buy
모두보기

Insmed Inc 주식(INSM)의 최신 뉴스

pulisher
Jan 20, 2025

Insmed CEO William Lewis sells shares worth $2.71 million - MSN

Jan 20, 2025
pulisher
Jan 20, 2025

Insmed Incorporated (NASDAQ:INSM) Short Interest Up 18.7% in December - MarketBeat

Jan 20, 2025
pulisher
Jan 20, 2025

Is Insmed (NASDAQ:INSM) Using Debt Sensibly? - Simply Wall St

Jan 20, 2025
pulisher
Jan 19, 2025

Insmed chief medical officer sells $95,108 in stock - MSN

Jan 19, 2025
pulisher
Jan 18, 2025

Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Yahoo Finance

Jan 18, 2025
pulisher
Jan 18, 2025

Insmed (FRA:IM8N) Shares Outstanding (EOP) : 178.8 Mil (As of Sep. 2024) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 18, 2025

Insmed's chief people strategy officer sells $59,923 in stock - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert - MSN

Jan 18, 2025
pulisher
Jan 17, 2025

Insmed Incorporated (NASDAQ:INSM) Insider Sells $95,108.48 in Stock - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 31,805 Shares of Stock - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed COO Roger Adsett sells $100,125 in stock - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

Hennion & Walsh Asset Management Inc. Sells 43,522 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Insmed chief medical officer sells $95,108 in stock By Investing.com - Investing.com Australia

Jan 17, 2025
pulisher
Jan 17, 2025

Assenagon Asset Management S.A. Has $36.26 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Insider Sell: Roger Adsett Sells 1,457 Shares of Insmed Inc (INS - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

Insider Sell: Schaeffer Orlov S Nicole Sells Shares of Insmed In - GuruFocus.com

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed's chief people strategy officer sells $59,923 in stock By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed COO Roger Adsett sells $100,125 in stock By Investing.com - Investing.com South Africa

Jan 16, 2025
pulisher
Jan 16, 2025

Insmed CEO William Lewis sells shares worth $2.71 million By Investing.com - Investing.com Canada

Jan 16, 2025
pulisher
Jan 15, 2025

Why INSM Stock Is Advancing Today - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Insmed’s gene therapy poised to challenge DMD landscape after IND clearance - Yahoo Finance

Jan 15, 2025
pulisher
Jan 14, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 14, 2025

Capital CS Group LLC Buys New Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Insmed (NASDAQ:INSM) Stock Price Up 6%Should You Buy? - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

How Is The Market Feeling About Insmed? - Benzinga

Jan 13, 2025
pulisher
Jan 11, 2025

Insmed issues preliminary revenue results, guidance for Arikayce - MSN

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed COO Roger Adsett sells $368,472 in stock By Investing.com - Investing.com Nigeria

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed chief commercial officer sells shares worth $659,800 By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed chief legal officer sells $242,815 in common stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed’s chief medical officer sells $725,820 in stock By Investing.com - Investing.com Nigeria

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed's chief medical officer sells $725,820 in stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed CFO Sara Bonstein sells $392,601 in stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Insmed Incorporated (NASDAQ:INSM) Stock Holdings Boosted by Harbor Capital Advisors Inc. - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Insmed's chief medical officer sells $725,820 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CFO Sara Bonstein sells $392,601 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CEO William Lewis sells $995,012 in stock By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed CEO William Lewis sells $995,012 in stock - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Insmed chief people strategy officer sells shares worth $312,259 By Investing.com - Investing.com Canada

Jan 10, 2025
pulisher
Jan 10, 2025

Roger Adsett Sells 2,444 Shares of Insmed Incorporated (NASDAQ:INSM) Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Sara Bonstein Sells 3,470 Shares of Insmed Incorporated (NASDAQ:INSM) Stock - MarketBeat

Jan 10, 2025

Insmed Inc (INSM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
자본화:     |  볼륨(24시간):